Alvaro P-L Profile
Alvaro P-L

@alvaropleone

Followers
802
Following
1K
Media
7
Statuses
855

Joined October 2015
Don't wanna be here? Send us removal request.
@danieltcorp
Daniel Corp
9 months
The NIBS field now has a data repository!!! 🙌🥳 We have now officially launched 'Big NIBS data' - an open-access platform and repository for non-invasive brain stimulation data! https://t.co/HzqYDnsgpw. A thread 🧵 (also see preprint: https://t.co/pwnnZIpL1v)
Tweet media one
1
18
44
@yusterafa
rafael yuste
9 months
Spain allocates initial funding for National Neurotechnology Center (#SpainNeurotech)
@oscarlopeztwit
Oscar López Agueda
9 months
Ponemos sobre la mesa los primeros 40 millones € para el Centro Nacional de Neurotecnología Neurotech. Un proyecto fruto de la colaboración entre el Gobierno de España, la Comunidad de Madrid y la Universidad Autónoma de Madrid. La investigación al servicio de las personas.
6
19
71
@bbs_lab
BBSLab - Barcelona Brain Stimulation Lab
1 year
🚨Excited to announce our new publication!🚨 Our study shows that repetitive negative thinking is linked to brain integrity in subjective cognitive decline (SCD). Now in Frontiers in Aging Neuroscience. 🔗 https://t.co/iwF7PWLOy1 @FrontiersIn
Tweet media one
0
4
7
@kabellanedap
Kilian Abellaneda
1 year
Our article on the effects of deep brain stimulation in patients with severe anorexia nervosa is now out in @ActaNeuro. https://t.co/lkjJBGyn6X
Tweet media one
1
3
11
@bibliotequesUAB
Biblioteques UAB
1 year
LLIBRES AL SOL | ☀️📚Avui us suggerim 'El cerebro que cura' dels neurocientífics @alvaropleone, @AlvaroF i @DBartres_Faz, publicat per @PlataformaEdit, el 2019 És una recomanació de @Bctuab https://t.co/Kmd01PSf4w #LlibresAlSol #bibuabrecomanem @UABBarcelona @PlataformaEdit
Tweet media one
Tweet media two
2
7
9
@yusterafa
rafael yuste
1 year
Neurotechnology Summer course July 10-12th in El Escorial (Madrid; in Spanish) @CursosVeranoUCM https://t.co/A7m6uzmFeZ
Tweet media one
0
12
31
@yusterafa
rafael yuste
1 year
Neurotechnology Summer Course in El Escorial (Madrid), July 10-12 (in Spanish). Registration is open.
Tweet media one
2
13
29
@yusterafa
rafael yuste
2 years
Testifying in Spanish Parliament on NeuroTech and Neurorights with Álvaro Pascual-Leone
Tweet media one
5
18
75
@hesheng3
Hesheng Liu
2 years
Jianxun showed strong evidence that SCAN network recently discovered by @ndosenbach is involved in Parkingson's, and this network may be modulated by DBS and TMS @foxmdphd @DavidRen555 @andreashorn_ @alvaropleone
@DavidRen555
Jianxun Ren (find me here @jianxunren.bsky.social)
2 years
🧠🎯Check out our new work on the somato-cogntive action network (SCAN) in #Parkinsonsdisease and its relationship with diverse neuromodulatory targets for PD. https://t.co/o7Qb8GMcp5 A few key findings below!🧵
0
10
31
@alvaropleone
Alvaro P-L
2 years
Building on work in a rodent model, @inesviolante, @nirgrossman, @eboyden3, et al show in a series of careful experiments that Temporal Interference Stimulation can non-invasively selectively modulate hippocampal activity in humans. https://t.co/EdU8d5IxOS
Tweet card summary image
nature.com
Nature Neuroscience - Electrical deep brain stimulation therapy is limited by the risks of inserting electrodes into the brain. Here the authors report non-invasive deep brain stimulation in the...
1
4
20
@DBartres_Faz
David Bartrés-Faz
2 years
@bbs_lab @geronsociety Fantastic work with implications for neuropsychological assessment in subjects with subjective cognitive decline (SCD), congrats to the 'Lidias' @lidia_mulet @Lidia_Vaque and the whole @bbs_lab and the @BBHI_cat teams! @UBneuroscience @IGuttmann
0
3
10
@H_SeniorLife
Hebrew SeniorLife
2 years
Still, @alvaropleone said, “being able to make it 6 months longer and attend your granddaughter’s graduation may be priceless.” Read more:
Tweet card summary image
bostonglobe.com
Medicare said it will broadly cover Leqembi, which costs $26,500 annually and was developed by Eisai and Cambridge-based Biogen.
0
1
2
@AlvaroF
Álvaro Fernández Ibáñez
2 years
Should doctors prescribe Leqembi (lecanemab) to women with early Alzheimer's Disease? The evidence-based answer is probably No
1
5
4
@alvaropleone
Alvaro P-L
2 years
An important new study providing novel insights into the nature of alterations of brain activity in #Alzheimers being specifically due to changes in oscillations
@ChrisSYBenwell
Chris Benwell
2 years
In our new pre-print, we find evidence that EEG changes in Alzheimer's disease are primarily oscillatory in nature, and not aperiodic. A multi-centre collaboration with @MKopcanova @LukeWTait @Tomdonoghue @MouhsinShafi @alvaropleone et al:
0
3
11
@ChrisSYBenwell
Chris Benwell
2 years
In our new pre-print, we find evidence that EEG changes in Alzheimer's disease are primarily oscillatory in nature, and not aperiodic. A multi-centre collaboration with @MKopcanova @LukeWTait @Tomdonoghue @MouhsinShafi @alvaropleone et al:
Tweet card summary image
biorxiv.org
Electroencephalography (EEG) has shown potential for identifying early-stage biomarkers of neurocognitive dysfunction associated with dementia due to Alzheimer’s disease (AD). A large body of...
3
25
61
@Sedolor
Sociedad Española del Dolor
2 years
CONFERENCIA JOSÉ LUIS MADRID ARIAS ▶️ Sueño y Dolor. Álvaro Pascual Leone @alvaropleone Presenta: José Antonio de Vera Reyes 📅Viernes 26 ⏰14.00 hs. 🌏Sala Plenaria #SEDolor23 #Dolor #Sueño
Tweet media one
1
1
0
@H_SeniorLife
Hebrew SeniorLife
2 years
Scheduled pit stops revolutionized the sport of motor racing in the 1960s as they enabled mechanics to diagnose and fix race car problems before they caused a breakdown or worse. In this @medcitynews column @alvaropleone says we need a similar transformation in brain care
1
1
4
@H_SeniorLife
Hebrew SeniorLife
2 years
Traveling with a partner who has #memoryloss can be daunting. But it’s not impossible. Learn more in our latest blog post ➡️ https://t.co/pgRHzgPmfR ✈️ 🏖️ 🍹
0
1
3
@DBartres_Faz
David Bartrés-Faz
2 years
‼️✌️Proud of our new paper @BBHI_cat with @IGuttmann @UBneuroscience @H_SeniorLife @alvaropleone long term changes on psych distress, loneliness, personal growth after COVID-19. Large proportion of subjects 'resilient'. Chronic-worsening ones more susceptible to pandemic events
Tweet media one
1
6
19